|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.44 | 89.46 | 104.56 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pharmaceuticals & Drugs
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
1177.00
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
|
03-05-2024
|
|
|
Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of US FDA Inspection at Unit II of Eugia Pharma Specialities Ltd. a wholly owned subsidiary of the Company'. |
|
|
|
03-05-2024
|
|
|
Aurobindo Pharma Limited has informed the Exchange regarding 'With reference to the above, we are submitting all the required details as per SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 with regard to an order received from the Deputy Commissioner, Punjagutta (ST) STU-1 of GST, Punjagutta Division, Hyderabad under the provisions of the Central Goods and Services Tax Act, 2017 and TGST Act 2017 for the FY 2018-19 demanding reversal of ITC and payment of GST amounting to Rs. 6,54,50,645 along with interest of Rs.5,92,20,900 and also levying a penalty of Rs. 65,51,354/-, the disclosure of which was submitted on May 2, 2024.'. |
|
|
|
02-05-2024
|
|
|
Aurobindo Pharma Limited has informed the Exchange about Acquisition |
|
|
|
02-05-2024
|
|
|
Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of Disposal of business assets of Eugia US Manufacturing LLC, a wholly owned step- down subsidiary of the Company'. |
|
|
|
02-05-2024
|
|
|
Aurobindo Pharma Limited has informed the Exchange regarding 'The Company has received an order from the Deputy Commissioner, Punjagutta (ST) STU-1 of GST, Punjagutta Division, Hyderabad passed under relevant provisions of the Central Goods and Services T |
|
|
|
23-04-2024
|
|
|
Aurobindo Pharma Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
23-04-2024
|
|
|
AUROBINDO PHARMA LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation |
|
|
|
22-04-2024
|
|
|
Aurobindo Pharma Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
22-04-2024
|
|
|
AUROBINDO PHARMA LIMITED has informed the Exchange about Loss of share certificates |
|
|
|
12-04-2024
|
|
|
K. Nithyananda Reddy on behalf of the promoter and Promoter Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
|
|
|
|
|
|
|